Kunio Yui
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
- Toxicology top 2%
- Forensic Toxicology and Drug Analysis
Papers in
-
- Neurotransmitter Receptor Influence on Behavior 31
- Neuroscience and Neuropharmacology Research 12
-
- Schizophrenia research and treatment 12
- Child Nutrition and Feeding Issues 11
- Co-authors
- Shigenori Ikemoto (20 shared papers)Takeo Ishiguro (17 shared papers)Kimihiko Goto (14 shared papers)George Imataka (20 shared papers)Koichi Nisijima (5 shared papers)Yohei Kawasaki (13 shared papers)Shun Nakamura (5 shared papers)Yuji Kobayashi (1 shared paper)
- Journals
- Annals of the New York Academy of Sciences (5 papers)Current Issues in Molecular Biology (4 papers)Drug and Alcohol Dependence (3 papers)Journal of Clinical Psychopharmacology (3 papers)CNS & Neurological Disorders - Drug Targets (2 papers)
- Partner nations
- JapanUnited States
In The Last Decade
Kunio Yui
65 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 97
- Biological Psychiatry 124
- Toxicology 108
- Cellular and Molecular Neuroscience 427
- Psychiatry and Mental health 352
- Behavioral Neuroscience 49
Countries citing papers authored by Kunio Yui
This map shows the geographic impact of Kunio Yui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kunio Yui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kunio Yui more than expected).
Fields of papers citing papers by Kunio Yui
This network shows the impact of papers produced by Kunio Yui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kunio Yui. The network helps show where Kunio Yui may publish in the future.
Co-authors
The 25 scholars most cited alongside Kunio Yui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 116 | |
| 2 | 2015 | 86 | |
| 3 | 1999 | 80 | |
| 4 | 2012 | 80 | |
| 5 | 2000 | 77 | |
| 6 | 2016 | 64 | |
| 7 | 2008 | 42 | |
| 8 | 1997 | 41 | |
| 9 | 2008 | 36 | |
| 10 | 2002 | 35 | |
| 11 | 2015 | 34 | |
| 12 | 2015 | 28 | |
| 13 | 2002 | 26 | |
| 14 | 2004 | 26 | |
| 15 | 2001 | 25 | |
| 16 | 2004 | 19 | |
| 17 | 2022 | 19 | |
| 18 | 2002 | 18 | |
| 19 | 2011 | 16 | |
| 20 | 2017 | 16 |
About Kunio Yui
Kunio Yui is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health, Cognitive Neuroscience, Biological Psychiatry and Molecular Biology, having authored 71 papers that have together received 1.1k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (31 papers), Autism Spectrum Disorder Research (17 papers), Tryptophan and brain disorders (14 papers), Neuroscience and Neuropharmacology Research (12 papers), Schizophrenia research and treatment (12 papers), Child Nutrition and Feeding Issues (11 papers), Treatment of Major Depression (7 papers) and Fatty Acid Research and Health (6 papers). The work is most often cited by research in Biological Psychiatry (124 citations), Toxicology (108 citations), Cellular and Molecular Neuroscience (427 citations), Psychiatry and Mental health (352 citations) and Behavioral Neuroscience (49 citations). Kunio Yui has collaborated with scholars based in Japan and United States. Frequent co-authors include Shigenori Ikemoto, Takeo Ishiguro, Kimihiko Goto, George Imataka, Koichi Nisijima, Yohei Kawasaki, Shun Nakamura, Yuji Kobayashi, Katsutoshi Shioda and Hiroyuki Nakamura. Their work appears in journals such as Annals of the New York Academy of Sciences, Current Issues in Molecular Biology, Drug and Alcohol Dependence, Journal of Clinical Psychopharmacology and CNS & Neurological Disorders - Drug Targets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.